Teri B Pearlstein

Summary

Affiliation: Brown University
Country: USA

Publications

  1. ncbi request reprint Use of psychotropic medication during pregnancy and the postpartum period
    Teri Pearlstein
    Alpert Medical School of Brown University, Women s Medicine Collaborative, 146 West River Street, Providence, RI 02904, USA
    Womens Health (Lond Engl) 9:605-15. 2013
  2. doi request reprint Psychotropic medications and other non-hormonal treatments for premenstrual disorders
    Teri Pearlstein
    Alpert Medical School of Brown University, Providence, RI 02912, USA
    Menopause Int 18:60-4. 2012
  3. pmc Perinatal depression: treatment options and dilemmas
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University and the Women s Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905, USA
    J Psychiatry Neurosci 33:302-18. 2008
  4. pmc Premenstrual dysphoric disorder: burden of illness and treatment update
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University and Women s Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905, USA
    J Psychiatry Neurosci 33:291-301. 2008
  5. ncbi request reprint Patient choice of treatment for postpartum depression: a pilot study
    T B Pearlstein
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI 02905, USA
    Arch Womens Ment Health 9:303-8. 2006
  6. ncbi request reprint Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation
    Teri B Pearlstein
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI 02905, USA
    Contraception 72:414-21. 2005
  7. ncbi request reprint Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder
    Teri Pearlstein
    Women s Behavioural Health Program, Women and Infants Hospital, 101 Dudley Street, Providence, RI 02905 2499, USA
    Expert Opin Pharmacother 3:979-91. 2002
  8. ncbi request reprint Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, Rhode Island, USA
    Drugs 62:1869-85. 2002
  9. ncbi request reprint Pretreatment pattern of symptom expression in premenstrual dysphoric disorder
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA
    J Affect Disord 85:275-82. 2005
  10. ncbi request reprint Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment
    Teri Pearlstein
    Women s Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905 2499, USA
    Am J Obstet Gynecol 188:887-95. 2003

Detail Information

Publications16

  1. ncbi request reprint Use of psychotropic medication during pregnancy and the postpartum period
    Teri Pearlstein
    Alpert Medical School of Brown University, Women s Medicine Collaborative, 146 West River Street, Providence, RI 02904, USA
    Womens Health (Lond Engl) 9:605-15. 2013
    ..This review of selected studies will highlight some of the current issues with the use of psychotropic medications during pregnancy and the postpartum period. ..
  2. doi request reprint Psychotropic medications and other non-hormonal treatments for premenstrual disorders
    Teri Pearlstein
    Alpert Medical School of Brown University, Providence, RI 02912, USA
    Menopause Int 18:60-4. 2012
    ..Anxiolytics, calcium, chasteberry and cognitive-behaviour therapy may also have a role in the treatment of premenstrual symptoms...
  3. pmc Perinatal depression: treatment options and dilemmas
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University and the Women s Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905, USA
    J Psychiatry Neurosci 33:302-18. 2008
    ....
  4. pmc Premenstrual dysphoric disorder: burden of illness and treatment update
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University and Women s Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905, USA
    J Psychiatry Neurosci 33:291-301. 2008
    ..In addition, other hormones that suppress ovulation, anxiolytics, cognitive therapy, chasteberry and calcium may be helpful...
  5. ncbi request reprint Patient choice of treatment for postpartum depression: a pilot study
    T B Pearlstein
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI 02905, USA
    Arch Womens Ment Health 9:303-8. 2006
    ..The objective of this pilot trial was to examine the clinical characteristics of women with PPD associated with treatment selection...
  6. ncbi request reprint Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation
    Teri B Pearlstein
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI 02905, USA
    Contraception 72:414-21. 2005
    ....
  7. ncbi request reprint Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder
    Teri Pearlstein
    Women s Behavioural Health Program, Women and Infants Hospital, 101 Dudley Street, Providence, RI 02905 2499, USA
    Expert Opin Pharmacother 3:979-91. 2002
    ..Fluoxetine is generally a well-tolerated treatment for PMDD and discontinuation effects have not been reported with intermittent dosing regimens...
  8. ncbi request reprint Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, Rhode Island, USA
    Drugs 62:1869-85. 2002
    ..Future research needs to address less frequent dose administration regimens, such as 'symptom-onset' dose administration, and the recommended length of treatment...
  9. ncbi request reprint Pretreatment pattern of symptom expression in premenstrual dysphoric disorder
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA
    J Affect Disord 85:275-82. 2005
    ..Use of intermittent dosing strategies for the treatment of premenstrual dysphoric disorder (PMDD) highlights the need for detailed empirical data on the onset, duration and pattern of symptom expression in women suffering from PMDD...
  10. ncbi request reprint Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment
    Teri Pearlstein
    Women s Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905 2499, USA
    Am J Obstet Gynecol 188:887-95. 2003
    ..The aim of this study was to use the data from two clinical trials to evaluate premenstrual dysphoric disorder symptom severity after the discontinuation of fluoxetine treatment...
  11. ncbi request reprint Depression and breastfeeding: which postpartum patients take antidepressant medications?
    Cynthia L Battle
    Brown Medical School, Providence, Rhode Island, USA
    Depress Anxiety 25:888-91. 2008
    ..No differences were found in age, race, or education...
  12. ncbi request reprint A preventive intervention for pregnant women on public assistance at risk for postpartum depression
    Caron Zlotnick
    Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA
    Am J Psychiatry 163:1443-5. 2006
    ..In this study, the authors examined whether the intervention would reduce the risk of postpartum major depressive disorder in a larger sample of pregnant women...
  13. ncbi request reprint Clinical characteristics of perinatal psychiatric patients: a chart review study
    Cynthia L Battle
    Brown Medical School, Department of Psychiatry and Human Behavior, Providence, Rhode Island, USA
    J Nerv Ment Dis 194:369-77. 2006
    ..For more than a third of the sample, the treatment sought while pregnant or postpartum represented their first contact with the mental health system. Treatment implications are discussed...
  14. ncbi request reprint Postpartum depression
    Teri Pearlstein
    Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, RI, USA
    Am J Obstet Gynecol 200:357-64. 2009
    ..Further research is needed to examine systematically the short-term and long-term effect of medication exposure through breastmilk on infant and child development...
  15. ncbi request reprint Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies
    Susan G Kornstein
    Virginia Commonwealth University School of Medicine, Richmond 23298 0710, USA
    J Clin Psychiatry 67:1624-32. 2006
    ....
  16. ncbi request reprint Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder
    Kimberly A Yonkers
    Department of Psychiatry, Yale University, New Haven, Connecticut 06510, USA
    Obstet Gynecol 106:492-501. 2005
    ..To compare the efficacy of a new low-dose oral contraceptive pill (OCP) formulation with placebo in reducing symptoms of premenstrual dysphoric disorder...